Proprotein Convertase 9/PCSK9 Monoclonal Antibody(Capture) (AN001270P)
For research use only.
| Verified Samples | Verified Samples in ELISA: Recombinant Human Proprotein Convertase 9/PCSK9 protein, Human serum, Human plasma |
| Dilution | ELISA Capture 2-8 μg/mL |
| Isotype | Mouse IgG1 |
| Host | Mouse |
| Reactivity | Human |
| Applications | ELISA Capture |
| Clonality | Monoclonal |
| Immunogen | Recombinant Human Proprotein Convertase 9/PCSK9 protein expressed by Mammalian |
| Abbre | Proprotein Convertase 9/PCSK9 |
| Synonyms | PCSK9, NARC1, PSEC0052, Proprotein convertase subtiLisin/kexin type 9, NeuraL apoptosis-reguLated convertase 1 (NARC-1), Proprotein convertase 9 (PC9), SubtiLisin/kexin-Like protease PC9 |
| Swissprot | |
| Concentration | 1 mg/mL |
| Buffer | Phosphate buffered solution, pH 7.2, containing 0.05% proclin 300. |
| Purification Method | Protein A/G Purification |
| Research Areas | Signal Transduction, Cardiovascular, Stem Cells, Cell Biology, Metabolism |
| Clone No. | 12C6 |
| Conjugation | Unconjugated |
| Storage | Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles. |
| Shipping | The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended. |
| background | Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (lDlR),very low density lipoprotein receptor (VlDlR),apolipoprotein E receptor (lRP1/APOER) and apolipoprotein receptor 2 (lRP8/APOER2),and promotes their degradation in intracellular acidic compartments.Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic lDlR through a clathrin lDlRAP1/ARH-mediated pathway. May prevent the recycling of lDlR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of lDlR leading to its subsequent degradation.Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a lDlR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway.Inhibits epithelial Na+ channel (ENaC)-mediated Na+ absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of lRP8/APOER2 levels and related anti-apoptotic signaling pathways. |
Other Clones
{{antibodyDetailsPage.numTotal}} Results
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
Other Formats
{{formatDetailsPage.numTotal}} Results
Unconjugated
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
-
IF：{{item.impact}}
Journal：{{item.journal}} ({{item.year}})
DOI：{{item.doi}}Reactivity：{{item.species}}
Sample Type：{{item.organization}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
